Cargando…

Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome

New-onset refractory status epilepticus (NORSE) is a drug-resistant status epilepticus that often has a catastrophic outcome. Our patient was diagnosed with NORSE and had an EEG reading that showed status epilepticus persisting for 8 months in general anesthesia. After autoimmune workup showed posit...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Khateeb, Mashael, Adem, Fatima, Moqbel, Amani, Baz, Salah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Riyadh : Armed Forces Hospital 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015520/
https://www.ncbi.nlm.nih.gov/pubmed/31380826
http://dx.doi.org/10.17712/nsj.2018.3.20180014
_version_ 1783673694701223936
author Al-Khateeb, Mashael
Adem, Fatima
Moqbel, Amani
Baz, Salah
author_facet Al-Khateeb, Mashael
Adem, Fatima
Moqbel, Amani
Baz, Salah
author_sort Al-Khateeb, Mashael
collection PubMed
description New-onset refractory status epilepticus (NORSE) is a drug-resistant status epilepticus that often has a catastrophic outcome. Our patient was diagnosed with NORSE and had an EEG reading that showed status epilepticus persisting for 8 months in general anesthesia. After autoimmune workup showed positive antiphospholipid antibodies, his seizure was controlled, and he was discharged with good condition apart from moderate cognitive impairment. However, he later developed schizophrenia. Although psychiatric disorders have been associated with antiphospholipid syndrome, to the best of our knowledge, it has not been reported to be associated with status epilepticus. We recommend vigilance of psychological complications of refractory status epilepticus’ patients for early psychiatric referral, diagnosis, and treatment.
format Online
Article
Text
id pubmed-8015520
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Riyadh : Armed Forces Hospital
record_format MEDLINE/PubMed
spelling pubmed-80155202021-08-13 Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome Al-Khateeb, Mashael Adem, Fatima Moqbel, Amani Baz, Salah Neurosciences (Riyadh) Case Report New-onset refractory status epilepticus (NORSE) is a drug-resistant status epilepticus that often has a catastrophic outcome. Our patient was diagnosed with NORSE and had an EEG reading that showed status epilepticus persisting for 8 months in general anesthesia. After autoimmune workup showed positive antiphospholipid antibodies, his seizure was controlled, and he was discharged with good condition apart from moderate cognitive impairment. However, he later developed schizophrenia. Although psychiatric disorders have been associated with antiphospholipid syndrome, to the best of our knowledge, it has not been reported to be associated with status epilepticus. We recommend vigilance of psychological complications of refractory status epilepticus’ patients for early psychiatric referral, diagnosis, and treatment. Riyadh : Armed Forces Hospital 2019-07 /pmc/articles/PMC8015520/ /pubmed/31380826 http://dx.doi.org/10.17712/nsj.2018.3.20180014 Text en Copyright: © Neurosciences https://creativecommons.org/licenses/by-nc-sa/3.0/Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.
spellingShingle Case Report
Al-Khateeb, Mashael
Adem, Fatima
Moqbel, Amani
Baz, Salah
Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome
title Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome
title_full Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome
title_fullStr Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome
title_full_unstemmed Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome
title_short Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome
title_sort schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015520/
https://www.ncbi.nlm.nih.gov/pubmed/31380826
http://dx.doi.org/10.17712/nsj.2018.3.20180014
work_keys_str_mv AT alkhateebmashael schizophreniafollowingnewonsetrefractorystatusepilepticussecondarytoantiphospholipidsyndrome
AT ademfatima schizophreniafollowingnewonsetrefractorystatusepilepticussecondarytoantiphospholipidsyndrome
AT moqbelamani schizophreniafollowingnewonsetrefractorystatusepilepticussecondarytoantiphospholipidsyndrome
AT bazsalah schizophreniafollowingnewonsetrefractorystatusepilepticussecondarytoantiphospholipidsyndrome